Trials / Completed
CompletedNCT02923154
Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
An Exploratory Study of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) (Placebo-Controlled Double-Blind Study)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy, safety, tolerability and pharmacokinetics of multiple oral administration of MT-3995 in patients with NASH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-3995 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2018-03-01
- Completion
- 2019-04-01
- First posted
- 2016-10-04
- Last updated
- 2019-09-06
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02923154. Inclusion in this directory is not an endorsement.